Kilroy Realty Corporation broke ground in June of 2021 on the second phase of construction at Oyster Point in South San Francisco. Comprising three buildings offering 860,000 sf of space, the $940 million project will provide leading-edge lab and office environments for biomedical and pharmaceutical tenants. LEED Gold sustainable design certification will be sought for the structures, which will incorporate 40,000-sf open floor plates, 22' by 33' column spacing, 16' floor-to-floor heights, and a floor load capacity of 125 pounds per square foot.
Featuring a state-of-the-art fitness facility, a conference center, and a large outdoor amphitheater, Oyster Point Phase Two will create an urban village with numerous amenities that will serve all five phases of the development. The 50-acre life sciences campus will encompass three million square feet upon completion.